What targeted drugs should be taken for nasopharyngeal carcinoma

Nasopharyngeal carcinoma is one of the common malignant tumors in China, ranking first among head and neck malignant tumors. Due to various reasons, the incidence of nasopharyngeal carcinoma has shown an upward trend, with higher incidence in southern China, such as Guangdong, Guangxi, Hunan and other provinces, especially in the central and western parts of Guangdong, such as Zhaoqing, Foshan and Guangzhou. This is not a good thing for everyone. Because if nasopharyngeal carcinoma is not treated well, it will threaten life. When treating it, comprehensive treatment is usually the best. So what targeted drugs are taken for nasopharyngeal carcinoma? Combining traditional Chinese and Western medicine to treat nasopharyngeal carcinoma is the right choice.

From the current status of nasopharyngeal carcinoma treatment research, combined chemotherapy is the main method at present, including adjuvant chemotherapy, neoadjuvant chemotherapy, synchronous chemoradiotherapy, molecular targeted therapy, etc. The indications of targeted treatment of nasopharyngeal carcinoma mainly include:

Some patients with advanced nasopharyngeal carcinoma (T3~4N0~1M0) and regionally advanced nasopharyngeal carcinoma (T1~2N2~3M0) should receive appropriate chemotherapy in addition to radiotherapy.

For patients with local advanced nasopharyngeal carcinoma (T3~4N2~3M0), their local recurrence rate and distant metastasis rate are quite high. Therefore, nasopharyngeal carcinoma must be combined with systemic treatment. The combination of Chinese and Western medicine has a certain effect in the treatment of nasopharyngeal carcinoma. Blood-activating and blood-stasis-removing drugs can improve microcirculation, increase blood flow, accelerate blood flow rate, and destroy the aggregation of fibrin around and inside tumor tissues, thereby improving the hypoxic tissue state.